Structural requirements of d-arabinose 5-phosphate isomerase (KdsD, E.C. 5.3.1.13) from Pseudomonas aeruginosa were analysed in detail using advanced NMR techniques. We performed epitope mapping studies of the binding between the enzyme and the most potent KdsD inhibitors found to date, together with studies of a set of newly synthesised arabinose 5-phosphate (A5P) mimetics. We report here the first experimental evidence that KdsD may bind the furanose form of A5P, suggesting that catalysis of ring opening may be an important part of KdsD catalysis.

Arabinose 5-phosphate isomerase as a target for antibacterial design : studies with substrate analogues and inhibitors / L. Gabrielli, S. Merlo, C. Airoldi, P. Sperandeo, S. Gianera, A. Polissi, F. Nicotra, T.P. Holler, R.W. Woodard, L. Cipolla. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 22:8(2014), pp. 2576-2583. [10.1016/j.bmc.2013.08.012]

Arabinose 5-phosphate isomerase as a target for antibacterial design : studies with substrate analogues and inhibitors

P. Sperandeo;A. Polissi;
2014

Abstract

Structural requirements of d-arabinose 5-phosphate isomerase (KdsD, E.C. 5.3.1.13) from Pseudomonas aeruginosa were analysed in detail using advanced NMR techniques. We performed epitope mapping studies of the binding between the enzyme and the most potent KdsD inhibitors found to date, together with studies of a set of newly synthesised arabinose 5-phosphate (A5P) mimetics. We report here the first experimental evidence that KdsD may bind the furanose form of A5P, suggesting that catalysis of ring opening may be an important part of KdsD catalysis.
d-Arabinose 5-phosphate isomerase; Enzyme inhibitors; Escherichia coli; Molecular recognition; NMR binding studies; Pseudomonas aeruginosa; Aldose-Ketose Isomerases; Anti-Bacterial Agents; Bacterial Proteins; Drug Design; Enzyme Inhibitors; Escherichia coli; Isomerism; Microbial Sensitivity Tests; Protein Binding; Pseudomonas aeruginosa; Recombinant Proteins; Substrate Specificity; Biochemistry; Clinical Biochemistry; Molecular Biology; Molecular Medicine; Organic Chemistry; Drug Discovery3003 Pharmaceutical Science; 3003; Medicine (all)
Settore BIO/19 - Microbiologia Generale
Settore CHIM/06 - Chimica Organica
   Outer membrane biogenensis in Gram negative bacteria as a target for innovative antibacterial drugs
   FONDAZIONE CARIPLO
   2010.0653

   Nuovi antibiotici mediante rational design
   REGIONE LOMBARDIA
   30190679
2014
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/468540
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 8
social impact